IL17A and arteriosclerosis: In apoE-deficient mice, a well-characterized model for arteriosclerosis, inhibition of IL-17A signalling reduced atherosclerotic lesion formation, prevented plaque rupture, and diminished levels of circulating proinflammatory cytokines [84]-[86].